GlassScriptPhysician profile
Alexa Hammock
NPI 1851152409
$3,562.90
in general payments reported to CMS, 2019-2025
32 companies · $1,779 in 2025
The $1,779 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,784 · 2025: $1,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,562.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $659.76 | 2024-2025 | |
| Lilly USA, LLC | $452.13 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $331.09 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $279.58 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.19 | 2024-2025 | Xifaxan |
| Pfizer INC. | $179.40 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $166.37 | 2024-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $150.07 | 2024-2025 | Trintellix |
| Dynavax Technologies Corporation | $104.41 | 2024 | Heplisav-B |
| Actelion Pharmaceuticals US, INC. | $100.66 | 2024-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.27 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $95.18 | 2024 | Watchman Flx |
| Amgen INC. | $89.75 | 2024-2025 | Evenity, Prolia, Prolia |
| Exact Sciences Corporation | $80.98 | 2024-2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $70.34 | 2024-2025 | Fanapt |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $67.31 | 2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $67.13 | 2024-2025 | Ajovy |
| Bausch Health US, LLC | $56.27 | 2024-2025 | Aplenzin, Wellbutrin |
| Philips North America LLC | $38.84 | 2024 | (Ck6) Holter |
| Esperion Therapeutics, INC. | $32.85 | 2024 | Nexletol |
| Viatris Specialty LLC | $31.27 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $25.09 | 2024 | |
| Dexcom, INC. | $21.50 | 2024 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $20.60 | 2024 | Injectafer |
| Abbott Laboratories | $18.68 | 2025 | Freestyle Libre 3 |
| Abiomed | $17.49 | 2024 | Impella |
| Glaxosmithkline, LLC. | $17.16 | 2025 | Shingrix, Arexvy |
| Watermark Medical, INC. | $16.71 | 2024 | |
| Edwards Lifesciences Corporation | $16.48 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amneal Pharmaceuticals LLC | $15.90 | 2025 | Unithroid |
| Cequr Corporation | $14.00 | 2025 | Cequr Simplicity |
| Ardelyx, INC. | $13.44 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Hammock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.